Baotou Dongbao Bio-Tech Co (300239) Fair Value & Analysis
Healthcare · CN · Market cap 3.1B CNY
Fair value as of: Jun 24, 2026
Analysis
Baotou Dongbao Bio-Tech Co (300239) currently trades at ¥5.41, while our model-based Fair Value estimate is ¥1.80 — implying the stock looks roughly 66.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored collagen jars. The company also provides organic fertilizers, water soluble fertilizers, and compound microbial fertilizers; and industrial grade calcium hydrogen phosphate and feed grade calcium hydrogen phosphate. In addition, it is involved in the research and development, production, and sale of biological organic fertilizers, as well as empty capsules, as well as sale of terminal collagen. The company's products have applications in thickener, stabilizer, emulsifier, softgel, confection, empty hard capsules, plasma substitute, powder, tablets, beverage, and capsules, as well as fertilizer…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Baotou Dongbao Bio-Tech Co (300239) undervalued?
What is the fair value of 300239?
What is the quality score of 300239?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.